Intravascular large B cell lymphoma: Proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition

International Journal of Hematology

Volumn 89, Issue 5, 2009, Pages 600-610

  Masaki, Yasufumi ^a   Dong, Lingli ^a,b   Nakajima, Akio ^a   Iwao, Haruka ^a   Miki, Miyuki ^a   Kurose, Nozomu ^a   Kinoshita, Eriko ^a   Nojima, Takayuki ^a   Sawaki, Toshioki ^a   Kawanami, Takafumi ^a   Tanaka, Masao ^a   Shimoyama, Kumiko ^a,c   Kim, Changi ^a,d   Fukutoku, Masaaki ^a,e   Kawabata, Hiroshi ^a,f   Fukushima, Toshihiro ^a   Hirose, Yuko ^a   Takiguchi, Tomoo ^a,g   Konda, Susumu ^a,g   Sugai, Susumu ^a,h   Umehara, Hisanori ^a   more..

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Futatsuya Hospital   (Japan)

^e National Hospital Organization   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g Uchinada Spa Hospital   (Japan)

^h Kudo General Hospital   (Japan)

Author keywords

Bone marrow involvement; Early clinical diagnosis; Random skin biopsy; Rituximab

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTRAVASCULAR LARGE B CELL LYMPHOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MALE; PHYSICAL PERFORMANCE; SERODIAGNOSIS;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR NEOPLASMS;

EID: 67749130647     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0304-7     Document Type: Article

References (48)

1. L Pfleger J Tappeiner 1959 Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgefäße (Reticuloendotheliose?) Hautarzt 10 363 369 (in German)
2. S Mori S Itoyama N Mohri A Shibuya T Hirose R Takanashi 1985 Cellular characteristics of neoplastic angiotheliosis: an immunohistological marker study of 6 cases Virchows Arch 407 167 175 10.1007/BF00737074
3. Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 252-3.
4. T Murase S Nakamura K Tashiro T Suchi J Hiraga N Hayasaki 1997 Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature Br J Haematol 99 656 664 10.1046/j.1365-2141.1997.4623265.x
5. T Murase S Nakamura 1999 An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma Leuk Lymphoma 33 459 473
6. T Murase S Nakamura K Kawauchi H Matsuzaki C Sakai T Inaba 2000 An Asian variant of intravascular lymphoma: clinical, pathologic, and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome Br J Haematol 111 826 834 10.1046/j.1365-2141.2000.02426.x (Pubitemid 32101416)
7. MR Wick SE Millis BW Scheithauer PH Cooper MA Davitz K Parkinson 1986 Reassessment of malignant "angioendothelimatosis": evidence in favor of its reclassification as "intravascular lymphomatosis" Am J Surg Pathol 10 112 123 10.1097/00000478-198602000-00004
8. JA DiGiuseppe WG Nelson EJ Seifter JK Boitnott RB Mann 1994 Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy J Clin Oncol 12 2573 2579
9. J Suzumiya K Ohshima M Kanda A Kato K Shuuda N Kimura 1998 Intravascular large cell lymphoma associated with hypoalbuminemia Leuk Lymphoma 32 179 182
10. KT Calamia A Miller EA Shuster C Perniciaro DM Menke 1999 Intravascular lymphomatosis: a report of ten patients with central nervous system involvement and a review of the disease process Adv Exp Med Biol 455 249 265
11. T Kobayashi S Munakata H Sugiura M Koizumi M Sumida K Murata 2000 Angiotropic lymphoma: proliferation of B cells in the capillaries of cutaneous angiomas Br J Dermatol 143 162 164 10.1046/j.1365-2133.2000.03608.x (Pubitemid 30485262)
12. R Watabe K Shibata N Hirase T Kodera K Muta J Nishimura 2000 Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hormone Ann Hematol 79 581 584 10.1007/s002770000188
13. T Tokura T Murase T Toriyama Y Totani M Negita K Akaza 2003 Asian variant of CD5+ intravascular large B-cell lymphoma with splenic infarction Intern Med 42 105 109 10.2169/internalmedicine.42.105
14. S Yoshikawa H Kobayashi S Kanda K Furihita M Ueno T Kaneki 2002 An Asian variant of intravascular large B-cell lymphoma diagnosed through splenectomy Intern Med 14 1215 1216 10.2169/internalmedicine.41.1215
15. MD Kraus D Jones NL Bartlett 1999 Intravascular lymphoma associated with endocrine dysfunction: a report of four cases and a review of the literature Am J Med 107 169 170 10.1016/S0002-9343(99)00191-6 (Pubitemid 29383973)
16. L Colomo A Lopez-Guillermo M Perales S Rives A Martinrz F Bosch 2003 Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma Blood 101 78 84 10.1182/blood-2002- 04-1286 (Pubitemid 36025890)
17. M Kanda J Suzumiya K Ohshima S Haraoka N Nakamura M Abe 2001 Analysis of the immunoglobulin heavy chain variable region of intravascular large B-cell lymphoma Virchows Arch 439 540 546 10.1007/s004280100398 (Pubitemid 32930180)
18. S Yegappan R Coupland DA Arber M Wang R Miocinovic RR Tubbs 2001 Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma Mod Pathol 14 1147 1156 10.1038/modpathol.3880450 (Pubitemid 33063209)
19. JA Ferry NL Harris LJ Picker DS Weinberg RK Rosales J Tapia 1988 Intravascular lymphomatosis (malignant angioendotheliomatosis): a B-cell neoplasm expressing surface homing receptors Mod Pathol 1 444 452
20. S Jalkanen R Aho M Kallajoki T Ekfors P Nortamo C Gahmberg 1989 Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis Int J Cancer 44 777 782 10.1002/ijc.2910440505 (Pubitemid 20007971)
21. M Kanda J Suzumiya K Ohshima K Tamura M Kikuchi 1999 Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies Leuk Lymphoma 34 569 580
22. T Murase K Tashiro T Suzuki H Saito S Nakamura 1998 Detection of antibodies to Fasciola and Anisakis in Japanese patients with intravascular lymphomatosis Blood 92 2182 2183
23. C Shimazaki T Inaba M Nakagawa 2000 B-cell lymphoma associated haemophagocytic syndrome Leuk Lymphoma 38 121 130
24. M Yamaguchi M Kimura Y Watanabe M Taniguchi M Masuya S Kageyama 2001 Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis Bone Marrow Transplant 27 89 91 10.1038/sj.bmt. 1702735 (Pubitemid 32124412)
25. AJ Ferreri E Campo JF Seymour R Willemze F Ilariucci A Ambrosetti 2004 International Extranodal Lymphoma Study Group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant' Br J Haematol 127 173 183 10.1111/j.1365-2141.2004.05177.x (Pubitemid 39371810)
26. AJ Ferreri E Campo A Ambrosetti F Ilariucci JF Saymour R Willemze 2004 Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma Ann Oncol 15 1215 1221 10.1093/annonc/mdh274 (Pubitemid 39199308)
27. T Murase M Yamaguchi R Suzuki M Okamoto Y Sato J Tamaru 2007 Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5 Blood 109 478 485 10.1182/blood-2006-01-021253 (Pubitemid 46105941)
28. M Bouzani T Karmitra D Rontogianni S Delimpassi J Apostolidis M Mpakiri 2006 Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy Oncologist 11 923 928 10.1634/theoncologist.11-8-923 (Pubitemid 44373765)
29. TS Davis 2003 Intravascular lymphoma presenting with cauda equine syndrome: treated with CHOP and rituxan Leuk Lymphoma 44 887 888 10.1080/1042819021000055291 (Pubitemid 36411000)
30. G Weichert M Martinka JK Rivers 2003 Intravascular lymphoma presenting as teleangectasias: response to rituximab and combination chemotherapy J Cutan Med Surg 7 460 463 10.1007/s10227-003-0153-6 (Pubitemid 38233355)
31. I Takacs N Eros I Bene F Bozso L Tordai Z Karolyi 2004 Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy Ann Hematol 83 608 610 10.1007/s00277-004-0897-0 (Pubitemid 39209188)
32. L Bazhenova P Higginbottom J Mason 2006 Intravascular lymphoma: a role for single-agent rituximab Leuk Lymphoma 47 337 341 10.1080/10428190500300837 (Pubitemid 43084577)
33. S Gill B Melosky L Haley C ChanYan 2003 Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin Am J Med 114 56 58 10.1016/S0002-9343(02)01378-5 (Pubitemid 36126517)
34. N Asada J Odawara S Kimura T Aoki M Kamakura M Takeuchi 2007 Use of random skin biopsy for diagnosis if intravascular large B cell lymphoma Mayo Clin Proc 82 1523 1531 10.4065/82.12.1525
35. B Coiffier E Lepage J Briere R Herbrecht H Tilly R Bouabdallah 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235 242 10.1056/NEJMoa011795 (Pubitemid 34438862)
36. M Pfreundscuh L Trumper A Osterborg R Perregell M Trneny K Imrie 2006 MabThera International Trial Group. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 10.1016/S1470-2045(06) 70664-7
37. K Shimada K Matsue K Yamamoto T Murase N Ichikawa M Okamoto 2008 Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group Jpn J Clin Oncol 26 3189 3195
38. AJ Ferreri GP Dognini O Bairey A Szomor C Montalban B Horvath 2008 The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma Br J Haematol 143 253 257 10.1111/j.1365-2141.2008.07338.x
39. CP Hans DD Weisenburger TC Greiner RD Gascoyne J Delabie G Ott 2004 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 275 282 10.1182/blood-2003-05-1545 (Pubitemid 38029949)
40. LH Sehn B Berry M Chhanabhai C Fitzqerald K Gill P Hoskins 2007 The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Blood 109 1857 1861 10.1182/blood-2006-08-038257 (Pubitemid 46348180)
41. M Mori K Kitamura M Masuda T Hotta T Miyazaki AB Miura 2005 Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma Int J Hematol 81 246 254 10.1532/IJH97.03147 (Pubitemid 41364491)
42. H Tsurumi T Hara N Goto K Kanemura S Kasahara M Sawada 2007 A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma Hematol Oncol 25 107 114 10.1002/hon.815 (Pubitemid 47507877)
43. T Kobayashi K Tobinai M Shimoyama C Mikuni S Konda M Kozuru 1999 Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group Jpn J Clin Oncol 29 340 348 10.1093/jjco/29.7.340
44. M Hirano M Okamoto F Maruyama K Ezaki K Shimizu T Ino 1992 Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study Cancer 69 772 777 10.1002/1097-0142(19920201)69:3<772::AID-CNCR2820690326>3.0.CO;2-Z
45. M Yamaguchi M Seto M Okamoto R Ichinohasama N Nakamura T Yoshino 2002 De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients Blood 99 815 821 10.1182/blood.V99.3.815 (Pubitemid 34525540)
46. AA Alizadeh MB Eisen RE Davis C Ma IS Lossos A Rosenwald 2000 Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 503 511 10.1038/35000501 (Pubitemid 30082188)
47. SJ Wu WC Chou BS Ko HF Tien 2007 Severe pulmonary complications after initial treatment with Rituximab for the Asian-variant of intravascular lymphoma Haematologica 92 141 142 10.3324/haematol.10561 (Pubitemid 46232679)
48. CH Moskowitz AD Zelenetz T Kewalramani P Hamlin S Lessac-Chenen J Houldsworth 2005 Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, dose not correlate with outcome in patients with relapsed and refractory DLBCL Blood 106 3383 3385 10.1182/blood-2005-04-1603 (Pubitemid 41609171)